Novartis aims to save $1bn by 2020 with integrated manufacturing plan
The savings will come from centralising manufacturing services and will complement the firm’s cost-saving business division launched last year.
The savings will come from centralising manufacturing services and will complement the firm’s cost-saving business division launched last year.
The manufacture of controlled substances has faced increased scrutiny over the years, and as such, fewer CMOs are in the market.
Exclusive Q&A
Regulations, recruitment and facility refits are holding continuous manufacturing back, but a Rutgers’ associate behind J&J’s recent success believes industry can overcome these hurdles.
Almac Group has expanded its serialization capabilities to include its US commercial packaging facility in Audubon, PA.
Worldwide Clinical Trials (WCT) has opened a clinical trial material storage depot in St Petersburg, Russia citing increasing customer demand.
3D printing can make drug production simpler and cheaper according to a UK expert who says using it for commercial production is about “numbering up” not scaling up.